Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium

Journal of Physiology and Biochemistry

Volumn 67, Issue 3, 2011, Pages 443-452

  Mercader, Josep ^a,b   Wanecq, Estelle ^a,b   Chen, Jian ^c   Carpéné, Christian ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c Syntech (SSPF) International Inc   (United States)

^d CHU RANGUEIL   (France)

Author keywords

Dietary supplements; Isoprenaline; Obesity; Octopamine; Rat adipocytes; Tyramine

Indexed keywords

ADRENALIN; AMINE OXIDASE (FLAVIN CONTAINING); DETERENOL; DRUG DERIVATIVE; GLUCOSE; ISOPRENALINE; LIPOTROPIC AGENT; METHYL 4 TYRAMINE; METHYL-4-TYRAMINE; OCTOPAMINE; OXEDRINE; PLANT EXTRACT; TYRAMINE;

ANIMAL; ARTICLE; CHEMISTRY; CITRUS; DRUG EFFECT; FEMALE; HUMAN; LIPOLYSIS; METABOLISM; OXIDATION REDUCTION REACTION; RAT; WHITE ADIPOSE TISSUE; WISTAR RAT;

ADIPOCYTES, WHITE; ADIPOSE TISSUE, WHITE; ANIMALS; CITRUS; EPINEPHRINE; FEMALE; GLUCOSE; HUMANS; ISOPROTERENOL; LIPOLYSIS; LIPOTROPIC AGENTS; MONOAMINE OXIDASE; OCTOPAMINE; OXIDATION-REDUCTION; PLANT EXTRACTS; RATS; RATS, WISTAR; SYNEPHRINE; TYRAMINE;

EID: 84862832974     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-011-0078-2     Document Type: Article

References (30)

1. Anderson WG (1983) The sympathomimetic activity of N-isopropyloctopamine in vitro. J Pharmacol Exp Ther 25:553-558
2. Arbo MD, Larentis ER, Linck VM, Aboy AL, Pimentel AL, Henriques AT, Dallegrave E, Garcia SC, LealMB, Limberger RP (2008) Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine. Food Chem Toxicol 46:2770-2775
3. Arbo MD, Schmitt GC, Limberger MF, Charão MF, Moro AM, Ribeiro GL, Dallegrave E, Garcia SC, Leal MB, Limberger RP (2009) Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice. Regul Toxicol Pharmacol 54:114 -117
4. Atgié C, Hadj-Sassi L, Bukowiecki L, Mauriège P (2009) High lipolytic activity and dyslipidemia in a spontaneous hypertensive/NIH corpulent (SHR/N-cp) rat: a genetic model of obesity and type 2 diabetes mellitus. J Physiol Biochem 65:33-42
5. Atgié C, Sauvant P, Ambid L, Carpéné C (2009) Possible mechanisms of weight loss of Siberian hamsters (Phodopus sungorus sungorus) exposed to short photoperiod. J Physiol Biochem 65:377-386
6. Bour S, Visentin V, Prévot D, Carpéné C (2003) Moderate weight-lowering effect of octopamine treatment in obese Zucker rats. J Physiol Biochem 59:175-182 (Pubitemid 38208129)
7. Bour S, Iglesias-Osma MC, Marti L, Duro P, Garcia-Barrado M, Pastor M-F, Prévot D, Visentin V, Valet P, Moratinos J, Carpéné C (2006) The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes. Eur J Pharmacol 552:20-30 (Pubitemid 44754973)
8. Carpéné C, Bousquet-Mélou A, Galitzky J, Berlan M, Lafontan M (1998) Lipolytic effects of beta1-, beta2-, and beta3-adrenergic agonists in white adipose tissue of mammals. Ann NY Sci 839:186-189
9. Carpéné C, Galitzky J, Fontana E, Atgié C, Lafontan M, Berlan M (1999) Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn-Schmiedeberg's Arch Pharmacol 359:310-321 (Pubitemid 29210962)
10. Dragull K, Breksa API, Cain B (2008) Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). J Agric Food Chem 56:8874-8878
11. Duffaut C, Bour S, Prévot D, Marti L, Testar X, Zorzano A, Carpéné C (2006) Prolonged treatment with the β3-adrenergic agonist CL 316243 induces adipose tissue remodeling in rat but not in guinea pig: 2) modulation of glucose uptake and monoamine oxidase activity. J Physiol Biochem 62:101-112 (Pubitemid 44920837)
12. Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB (2006) Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev 7:79-88
13. Haller CA, Duan M, Pr J, Benowitz N (2008) Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. Br J Clin Pharmacol 65:833-840 (Pubitemid 351677437)
14. Holt A, Smith DJ, Cendron L, Zanotti G, Rigo A, DiPaolo ML (2008) Multiple binding sites for substrates and modulators of semicarbazide-sensitive amine oxidases: kinetic consequences. Mol Pharmacol 73:525-538 (Pubitemid 351181186)
15. Iglesias-Osma MC, Bour S, Garcia-Barrado MJ, Visentin V, Pastor MF, Testar X, Marti L, Enrique-Tarancon G, Valet P, Moratinos J, Carpéné C (2005) Methylamine but not mafenide mimics insulin-like actvity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism. Pharmacol Res 52:475- 484
16. Lincová D, Cepelík J, Cernohorský M, Elisová K (1977) Effect of different albumin media on the lipid-mobilizing action of sympathicotropic substances in vitro. Physiol Bohemoslov 2:165-172
17. Ma G, Bavadekar SA, Schaneberg BT, Khan IA, Feller DR (2010) Effects of synephrine and beta-phenethylamine on human alpha-adrenoceptor subtypes. Planta Med 76:981-986
18. Mercolini L, Mandrioli R, Trerè T, Bugamelli F, Ferranti A, Raggi MA (2010) Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements. J Sep Sci 33:2520-2527
19. Nelson BC, Putzbach K, Sharpless KE, Sander LC (2007) Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium). J Agric Food Chem 55:9769-9775 (Pubitemid 350305158)
20. Pellati F, Benvenuti S (2007) Chromatographic and electrophoretic methods for the analysis of phenethylamine alkaloids in Citrus aurantium. J Chromatogr A 1161:71-88 (Pubitemid 47088510)
21. Pellati F, Benvenuti S (2007) Fast high-performance liquid chromatography analysis of phenethylamine alkaloids in Citrus natural products on a pentafluorophenylpropyl stationary phase. J Chromatogr A 1165:58-66 (Pubitemid 47313419)
22. Pellati F, Cannazza G, Benvenuti S (2010) Study on the racemization of synephrine by off-column chiral high-performance liquid chromatography. J Chromatogr A 1217:3503-3510
23. Percy DW, Adcock JL, Conlan XA, Barnett NW, Gange ME, Noonan LK, Henderson LC, Francis PS (2010) Determination of Citrus aurantium protoalkaloids using HPLC with acidic potassium permanganate chemiluminescence detection. Talanta 80:2191- 2195
24. Stich V, De Glisezinski I, Crampes F, Hejnova J, Cottet-Emard JM, Galitzky J, Lafontan M, Rivière D, Berlan M (2000) Activation of alpha2-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am J Physiol 279:R499-R504
25. Stohs SJ, Shara M (2007) A review of the safety and efficacy of Citrus aurantium in weight management. In: Bagchi D, Preuss HG (eds) Obesity: epidemiology, pathophysiology, and prevention. CRC, Boca Raton, pp 371-382
26. Tsujita T, Takaku T (2007) Lipolysis induced by segment wall extract from Satsuma mandarin orange (Citrus unshu Mark). J Nutr Sci Vitaminol (Tokyo) 53:547-551 (Pubitemid 351154878)
27. Visentin V, Morin N, Fontana E, Prévot D, Boucher J, Castan I, Valet P, Grujic D, Carpéné C (2001) Dual action of octopamine on glucose transport into adipocytes: inhibition via b3-adrenoceptor activation and stimulation via oxidation by amine oxidases. J Pharmacol Exp Ther 299:96-104 (Pubitemid 32905123)
28. Visentin V, Prevot D, Marti L, Carpéné C (2003) Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates. Eur J Pharmacol 466:235-243 (Pubitemid 36412086)
29. Wanecq E, Prévot D, Carpéné C (2009) Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes. J Physiol Biochem 65:351-360
30. Wenkeová J, Kuhna E, Wenke M (1975) Adrenergic lipolysis in human adipose tissue in vitro. Eur J Pharmacol 30:49-55